Umamaheswari Ramachandran

Array ( [id] => 6314392 [patent_doc_number] => 20100111985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'VACCINE COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/610964 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5386 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111985.pdf [firstpage_image] =>[orig_patent_app_number] => 12610964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4629559 [patent_doc_number] => 08008450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Therapeutic use of anti-CS1 antibodies' [patent_app_type] => utility [patent_app_number] => 12/610899 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 43224 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008450.pdf [firstpage_image] =>[orig_patent_app_number] => 12610899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985547 [patent_doc_number] => 20110097748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'USE OF CELL LINES TO DETERMINE LEVELS OF EFFICACY OF PHARMACEUTICAL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/607199 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5771 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097748.pdf [firstpage_image] =>[orig_patent_app_number] => 12607199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669079 [patent_doc_number] => 20110318348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'INDUCTION OF MUCOSAL IMMUNE RESPONSES BY MUCOSAL DELIVERY PENTABODY COMPLEX (MDPC)' [patent_app_type] => utility [patent_app_number] => 13/124062 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7291 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13124062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6485750 [patent_doc_number] => 20100093006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'HIGH AFFINITY ANTI-N1,N12-DIACETYLSPERMINE MONOCLONAL ANTIBODY' [patent_app_type] => utility [patent_app_number] => 12/578322 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8385 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093006.pdf [firstpage_image] =>[orig_patent_app_number] => 12578322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10882004 [patent_doc_number] => 08906381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Immunonanotherapeutics that provide IGG humoral response without T-cell antigen' [patent_app_type] => utility [patent_app_number] => 13/123887 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 98 [patent_no_of_words] => 83486 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13123887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499532 [patent_doc_number] => 20110262478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Recombinant Protein Bodies as Immunogen-Specific Adjuvants' [patent_app_type] => utility [patent_app_number] => 13/123510 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18833 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262478.pdf [firstpage_image] =>[orig_patent_app_number] => 13123510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499532 [patent_doc_number] => 20110262478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Recombinant Protein Bodies as Immunogen-Specific Adjuvants' [patent_app_type] => utility [patent_app_number] => 13/123510 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18833 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262478.pdf [firstpage_image] =>[orig_patent_app_number] => 13123510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302333 [patent_doc_number] => 20100068205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'Methionine Sulfoxide Antibodies' [patent_app_type] => utility [patent_app_number] => 12/574279 [patent_app_country] => US [patent_app_date] => 2009-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7213 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068205.pdf [firstpage_image] =>[orig_patent_app_number] => 12574279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289838 [patent_doc_number] => 20100158898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'METHODS OF TREATING IgE-MEDIATED DISORDERS COMPRISING THE ADMINISTRATION OF HIGH CONCENTRATION ANTI-IgE ANTIBODY FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 12/573801 [patent_app_country] => US [patent_app_date] => 2009-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33141 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158898.pdf [firstpage_image] =>[orig_patent_app_number] => 12573801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348512 [patent_doc_number] => 20100021461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'IMMUNOGLOBULIN FORMULATION AND METHOD OF PREPARATION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/572978 [patent_app_country] => US [patent_app_date] => 2009-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8933 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021461.pdf [firstpage_image] =>[orig_patent_app_number] => 12572978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574960 [patent_doc_number] => 20100129383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'BIFUNCTIONAL FUSION MOLECULES FOR THE DELIVERY OF ANTIGENS TO PROFESSIONAL ANTIGEN-PRESENTING CELLS' [patent_app_type] => utility [patent_app_number] => 12/571872 [patent_app_country] => US [patent_app_date] => 2009-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14973 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129383.pdf [firstpage_image] =>[orig_patent_app_number] => 12571872 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314961 [patent_doc_number] => 20100112078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'POLYMER PARTICLES BASED VACCINE' [patent_app_type] => utility [patent_app_number] => 12/567273 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11693 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112078.pdf [firstpage_image] =>[orig_patent_app_number] => 12567273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13853789 [patent_doc_number] => 10188600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-29 [patent_title] => Stable liquid antibody formulation [patent_app_type] => utility [patent_app_number] => 13/119784 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28354 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13119784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652651 [patent_doc_number] => 08372396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Antibody formulations' [patent_app_type] => utility [patent_app_number] => 12/554194 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 44 [patent_no_of_words] => 40957 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12554194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6308203 [patent_doc_number] => 20100069617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'ENHANCED PROTEIN AGGREGATE REMOVAL BY MIXED MODE CHROMATOGRAPHY ON HYDROPHOBIC INTERACTION MEDIA IN THE PRESENCE OF PROTEIN-EXCLUDED ZWITTERIONS' [patent_app_type] => utility [patent_app_number] => 12/553466 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4368 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069617.pdf [firstpage_image] =>[orig_patent_app_number] => 12553466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223899 [patent_doc_number] => 20100056765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'Formulations That Inhibit Protein Aggregation' [patent_app_type] => utility [patent_app_number] => 12/547272 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5829 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056765.pdf [firstpage_image] =>[orig_patent_app_number] => 12547272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355041 [patent_doc_number] => 08673574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Diagnosis and monitoring of renal failure using peptide biomarkers' [patent_app_type] => utility [patent_app_number] => 12/544605 [patent_app_country] => US [patent_app_date] => 2009-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9118 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12544605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5398271 [patent_doc_number] => 20090318334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-24 [patent_title] => 'LACTOFERRIN AS AN AGENT IN THE PREVENTION OF ORGAN TRANSPLANT REJECTION AND GRAFT-VERSUS-HOST-DISEASE' [patent_app_type] => utility [patent_app_number] => 12/542620 [patent_app_country] => US [patent_app_date] => 2009-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10304 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20090318334.pdf [firstpage_image] =>[orig_patent_app_number] => 12542620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6220002 [patent_doc_number] => 20100055097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION OF IGG ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/540320 [patent_app_country] => US [patent_app_date] => 2009-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7358 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20100055097.pdf [firstpage_image] =>[orig_patent_app_number] => 12540320 [rel_patent_id] =>[rel_patent_doc_number] =>)